Orchid Pharma Limited (NSE: ORCHPHARMA)
1,490.85
+31.75 (2.18%)
Sep 6, 2024, 3:30 PM IST
Orchid Pharma Revenue
Orchid Pharma had revenue of 2.44B INR in the quarter ending June 30, 2024, with 33.61% growth. This brings the company's revenue in the last twelve months to 8.81B, up 22.71% year-over-year. In the fiscal year ending March 31, 2024, Orchid Pharma had annual revenue of 8.19B with 23.05% growth.
Revenue (ttm)
8.81B
Revenue Growth
+22.71%
P/S Ratio
8.18
Revenue / Employee
10.11M
Employees
871
Market Cap
75.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 8.19B | 1.53B | 23.05% |
Mar 31, 2023 | 6.66B | 1.06B | 19.00% |
Mar 31, 2022 | 5.60B | 1.09B | 24.33% |
Mar 31, 2021 | 4.50B | -337.41M | -6.97% |
Mar 31, 2020 | 4.84B | -1.16B | -19.36% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries Limited | 9,252.89B |
Tata Consultancy Services Limited | 2,441.25B |
HDFC Bank Limited | 2,663.37B |
Bharti Airtel Limited | 1,510.49B |
ICICI Bank Limited | 1,686.78B |
Infosys Limited | 1,555.41B |
State Bank of India | 3,319.63B |
Hindustan Unilever Limited | 621.07B |